IRLAB THERAPEUTICS AB SER. A revenue for the last year amounted to 5.70 M SEK, the most of which — 61.14 M SEK — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 207.78 M SEK. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought IRLAB THERAPEUTICS AB SER. A 61.14 M SEK, and the year before that — 207.78 M SEK.